Description
P41 Impact of stopping tyrosine kinase inhibitor therapy on the molecular workload for monitoring: a single centre experience
Article: P41 Impact of stopping tyrosine kinase inhibitor therapy on the molecular workload for monitoring: a single centre experience
€2.42
Related products
-
1 year access Online Belgian Journal of Hematology (BJH)
€43.60 Add to cart -
Article: INTRODUCTION
€2.42 Add to cart -
1 year subscription print edition of the Belgian Journal of Hematology (BJH)
€147.15 Add to cart -
Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma
€2.42 Add to cart
